Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
González-Rodríguez, Alexandre
Monreal, José A.
and
V. Seeman, Mary
2022.
Factors Influencing Adherence to Antipsychotic Medications in Women with Delusional
Disorder: A Narrative Review.
Current Pharmaceutical Design,
Vol. 28,
Issue. 15,
p.
1282.
Lähteenvuo, Markku
Paljärvi, Tapio
Tanskanen, Antti
Taipale, Heidi
and
Tiihonen, Jari
2023.
Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study
.
The British Journal of Psychiatry,
Vol. 223,
Issue. 4,
p.
456.
Rosenheck, Robert
Anand, Sonia T.
Kurtz, Stephen G.
Hau, Cynthia
Smedberg, Diane
Pontzer, James F.
Ferguson, Ryan E.
and
Davis, Cynthia R.
2023.
Can multisite clinical trial results change clinical practice? Use of long-acting injectable risperidone nationally in the Veterans Health Administration.
Trials,
Vol. 24,
Issue. 1,
Citrome, Leslie
Correll, Christoph
Cutler, Andrew
Dunbar, Martin
Hoberg, Amber
Hopkinson, Craig
Mattingly, Gregory
McGrory, James
Rege, Bhaskar
Weiden, Peter
and
McDonnell, David
2025.
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.
Neuropsychiatric Disease and Treatment,
Vol. Volume 21,
Issue. ,
p.
575.
Sun, Christina
Temelie, Andreea
Goulding, Hannah
Clark, Christine
Yabs, Melanie
and
Fabian, Tanya
2025.
Long-Acting Injectable Antipsychotic Initiation in Child and Adolescent Patients with Psychiatric Disorders.
Journal of Child and Adolescent Psychopharmacology,
Vol. 35,
Issue. 2,
p.
80.